Adam Feuerstein Does Not Think AMAG Pharma Will Be Sold Until After Phase 3 Data

Adam Feuerstein, Senior Biotech Columnist at TheStreet.com, tweeted this morning that he believes AMAG Pharmaceuticals AMAG will eventually be sold, but not before the release of its phase 3 data in a couple months. AMAG Pharmaceuticals announced this morning that it has hired Jefferies & Company as a strategic advisor. Shares of AMAG Pharma are currently trading up over 4% .
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersFDAM&AGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!